In this dynamic and rapidly evolving landscape, continued innovation, strategic investments, and collaboration across the pharmaceutical industry will be key to unlocking the full potential of GLP-1 receptor agonists
Maintaining a written or digital log of injection sites can help patients track their rotation pattern, particularly during the initial months of therapy when establishing routine
This guide breaks it all down based on science, real user stories, and expert insights
Only a healthcare provider can evaluate the complete health profile and determine whether GLP-1 therapy is right for the patient
Results: A total of 329,577 MASLD pts at baseline were included in the analysis (prevalent PLC cases, incident PLC within one-year follow-up, and those lacking follow-up data post-index date were excluded)